1-3 of 3
Roy A. Beveridge, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Disease Progression On Healthcare Cost and Resource Utilization Among Follicular NHL Patients Treated within the US Oncology Network.

Stephen K Gruschkus, PhD, Joseph M Darragh, MA, Michael A Kolodziej, MD, Roy A Beveridge, MD, Michael Forsyth, RPh, MBA, Carolina Reyes, PhD
Journal: Blood
Blood (2009) 114 (22): 4543.
https://doi.org/10.1182/blood.V114.22.4543.4543
Published: 2009
Journal Articles

An Observational, Retrospective Analysis of Retreatment with Bortezomib of Mulitple Myeloma (MM) Patients.

Therese M. Conner, MS, PhD, QuynhChau D. Doan, RPh, MS, PhD, Annette L. LeBlanc, MT, Ian B. Walters, MD, Roy A. Beveridge, MD
Journal: Blood
Blood (2006) 108 (11): 3531.
https://doi.org/10.1182/blood.V108.11.3531.3531
Published: 2006
Journal Articles

Interim Analysis of a Phase II Trial of Bortezomib in Patients with Multiple Myeloma Who Failed To Achieve a Complete Response to Autologous Peripheral Blood Stem Cell Transplantation.

Robert M. Rifkin, MD, Roy A. Beveridge, MD, Mark W. Brunvand, MD, Gary Spitzer, MD, Boehm A. Kristi, MS, Mary Ann Rauch, BS, Feng Zhan, PhD, Lina Asmar, PhD
Journal: Blood
Blood (2005) 106 (11): 5176.
https://doi.org/10.1182/blood.V106.11.5176.5176
Published: 2005